CRDF vs EMN · rev $145.0K vs P/E 21, rev $9.38B
Cardiff Oncology Inc (CRDF) versus Eastman Chemical Company (EMN) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
Eastman Chemical Company (EMN) is a specialty chemicals company listed on US.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported EMN revenue for 2024-12-31 was $9.38B. Net income was $908.0M. Revenue was up 1.9% from 2023-12-31 to 2024-12-31. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
CRDF currently screens at market cap $238.8M. EMN currently screens at market cap $8.21B and trailing P/E 20.8.
Not investment advice. Open the CRDF and EMN stock pages for the full models.
Not investment advice.